Pierre Ferre - 29 Jul 2026 Form 4 Insider Report for COMPUGEN LTD (CGEN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
30 Jul 2026, 16:07:46 UTC
Prior SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Pierre Ferre

Key filing fact

Pierre Ferre filed Form 4 for COMPUGEN LTD (CGEN) on 30 Jul 2026.

Key facts

  • This page summarizes Pierre Ferre's Form 4 filing for COMPUGEN LTD (CGEN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 30 Jul 2026, 16:07.

Change

  • Previous filing in this sequence was filed on 18 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001972518 Primary reporting owner

Ferre Pierre

Relationship
Chief Operating Officer
Address
C/O COMPUGEN LTD., 26 HAROKMIM STREET, HOLON, ISRAEL
Signature
/s/ Pierre Ferre
Signature date
30 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CGEN transaction Derivative

Share Option (right to buy)

Award

Transaction value
Shares
+70,000
Change %
Price
$0.000000*
Shares after
70,000
Date
29 Jul 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
70,000
Exercise price
$4.00
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option vests 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .